Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Novavax Inc NVAX

Healthcare Biotechnology
Novavax, Inc. is a biotechnology company, which discovers, develops and commercializes vaccines to prevent serious infectious diseases. The Company offers a differentiated vaccine platform that combines a recombinant protein approach, advanced nanoparticle technology and its patented Matrix-M adjuvant to enhance the immune response. It has one commercial program, for vaccines to prevent COVID... see more

Recent & Breaking News (NDAQ:NVAX)

Novavax to Participate in the 4th Annual Guggenheim Boston Healthcare Conference

GlobeNewswire December 6, 2016

Novavax to Participate in the Citi 2016 Global Healthcare Conference

GlobeNewswire November 30, 2016

Novavax to Present at the 28th Annual Piper Jaffray Healthcare Conference

GlobeNewswire November 22, 2016

Biotech Stocks Under Review -- Novavax, Gilead Sciences, Ariad Pharma, and Exelixis

PR Newswire November 21, 2016

Mid-Afternoon Market Update: Dow Jumps Over 250 Points; Novavax Shares Slide

Benzinga.com  November 10, 2016

15 Biggest Mid-Day Losers For Thursday

Benzinga.com  November 10, 2016

12 Stocks You Should Be Watching Today

Benzinga.com  November 10, 2016

Novavax Posts Mixed Q3 Results, Announces Restructuring And Update On RSV Program

Benzinga.com  November 9, 2016

Novavax Reports Third Quarter 2016 Financial Results

GlobeNewswire November 9, 2016

UPDATE -- Novavax to Host Conference Call to Discuss Third Quarter Financial Results on November 9, 2016

GlobeNewswire November 2, 2016

Novavax to Host Conference Call to Discuss Third Quarter Financial Results on November 9, 2016

GlobeNewswire November 2, 2016

Mid-Morning Market Update: Markets Open Lower; Silicon Motion Raises Q3 Forecast

Benzinga.com  October 7, 2016

Novavax Reschedules 4th Annual Investor and Analyst Meeting

GlobeNewswire October 7, 2016

Novavax to Host 4th Annual Investor and Analyst Meeting

GlobeNewswire October 4, 2016

15 Biggest Mid-Day Gainers For Thursday

Benzinga.com  September 22, 2016

The Biggest Pharma Stock Blowups Of 2016

Benzinga.com  September 19, 2016

After Phase 3 Novavx Trial Misses Endpoints, Piper Downgrades Despite Remaining Vaccine Efforts

Benzinga.com  September 16, 2016

Mid-Afternoon Market Update: Dow Falls 100 Points; Crude Oil Down 2.3%

Benzinga.com  September 16, 2016

10 Biggest Mid-Day Losers For Friday

Benzinga.com  September 16, 2016

Mid-Day Market Update: Novavax Tumbles Following Failed Trial; Depomed Shares Surge

Benzinga.com  September 16, 2016